Vertex Pharmaceuticals
VRTX
VRTX
478 hedge funds and large institutions have $27.5B invested in Vertex Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 194 increasing their positions, 155 reducing their positions, and 47 closing their positions.
Holders
478
Holders Change
+4
Holders Change %
+0.84%
% of All Funds
12.75%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
61
Increased
194
Reduced
155
Closed
47
Calls
$80.4M
Puts
$97.3M
Net Calls
-$16.9M
Net Calls Change
+$182M
Top Buyers
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.59B |
| 2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$1.81B |
| 3 |
O
3
OrbiMed
New York
|
$15.9M |
| 4 |
4
Capital World Investors
Los Angeles,
California
|
$2.77B |
| 5 |
5
Millennium Management
New York
|
$10.5M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
526
Two Sigma Advisers
New York
| – | – | – | – |
|
|
ACP
527
Acuta Capital Partners
Redwood City,
California
| – | – | – | – |
|
|
PG
528
PEAK6 Group
Chicago,
Illinois
| – | – | – | – |
|
|
SM
529
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
|
ID
530
Integral Derivatives
New York
| – | – | – | – |
|